FR2309211B1 - - Google Patents

Info

Publication number
FR2309211B1
FR2309211B1 FR7612617A FR7612617A FR2309211B1 FR 2309211 B1 FR2309211 B1 FR 2309211B1 FR 7612617 A FR7612617 A FR 7612617A FR 7612617 A FR7612617 A FR 7612617A FR 2309211 B1 FR2309211 B1 FR 2309211B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7612617A
Other languages
French (fr)
Other versions
FR2309211A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2309211A1 publication Critical patent/FR2309211A1/fr
Application granted granted Critical
Publication of FR2309211B1 publication Critical patent/FR2309211B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7612617A 1975-04-28 1976-04-28 Suspension de cefazoline pour administration parenterale Granted FR2309211A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/573,283 US4029782A (en) 1975-04-28 1975-04-28 Cefazolin suspension for parenteral administration

Publications (2)

Publication Number Publication Date
FR2309211A1 FR2309211A1 (fr) 1976-11-26
FR2309211B1 true FR2309211B1 (https=) 1979-03-23

Family

ID=24291351

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7612617A Granted FR2309211A1 (fr) 1975-04-28 1976-04-28 Suspension de cefazoline pour administration parenterale

Country Status (8)

Country Link
US (1) US4029782A (https=)
JP (1) JPS51130522A (https=)
AU (1) AU505940B2 (https=)
BE (1) BE841157A (https=)
DE (1) DE2618422A1 (https=)
FR (1) FR2309211A1 (https=)
GB (1) GB1546479A (https=)
ZA (1) ZA761476B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
GB8322364D0 (en) * 1983-08-19 1983-09-21 May & Baker Ltd Compositions of matter
US6660049B1 (en) 1996-07-31 2003-12-09 Natural Soda Aala, Inc. Process for control of crystallization of inorganics from aqueous solutions
US6495164B1 (en) * 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
RU2310450C2 (ru) * 2002-10-25 2007-11-20 Пфайзер Продактс Инк. Новые депо-препараты для инъекций

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297692A (en) * 1961-04-03 1967-01-10 Lilly Co Eli 7-alkylmercaptoacetamidocephalosporanic acid
GB1051746A (https=) * 1961-12-22
US3293133A (en) * 1963-04-24 1966-12-20 Squibb & Sons Inc Method of imparting color to pharmaceutical solutions
CH557381A (de) * 1967-04-15 1974-12-31 Fujisawa Pharmaceutical Co Verfahren zur herstellung von (delta)3-cephemverbindungen.
GB1244501A (en) * 1968-03-09 1971-09-02 Aspro Nicholas Ltd Heterocyclic amines
US3678163A (en) * 1969-06-02 1972-07-18 Merck & Co Inc Stabilized aqueous suspension of calcium (-) (cis-1,2-epoxypropyl)-phosphonate
US3897423A (en) * 1973-03-05 1975-07-29 Squibb & Sons Inc Amino substituted acylthio cephalosporins

Also Published As

Publication number Publication date
ZA761476B (en) 1977-10-26
BE841157A (fr) 1976-10-27
AU1186876A (en) 1977-09-15
DE2618422A1 (de) 1976-11-11
JPS51130522A (en) 1976-11-12
GB1546479A (en) 1979-05-23
US4029782A (en) 1977-06-14
FR2309211A1 (fr) 1976-11-26
AU505940B2 (en) 1979-12-06

Similar Documents

Publication Publication Date Title
FR2317334B1 (https=)
FR2326409B2 (https=)
FR2301114B1 (https=)
FR2309211B1 (https=)
JPS5533635Y2 (https=)
JPS5510041Y2 (https=)
JPS5243721B1 (https=)
JPS51118176U (https=)
JPS51158176U (https=)
JPS5190943U (https=)
JPS5196963U (https=)
JPS5285440U (https=)
JPS5255473U (https=)
AU8233875A (https=)
CS175926B1 (https=)
CH602504A5 (https=)
CH587393A5 (https=)
CH603552A5 (https=)
CH603178A5 (https=)
CH603090A5 (https=)
CH603817A5 (https=)
CH602844A5 (https=)
CH583874A5 (https=)
BG22877A1 (https=)
CH601036A5 (https=)

Legal Events

Date Code Title Description
ST Notification of lapse